Branched fatty acid esters of hydroxy fatty acids (FaHFas) are a recently discovered class of endogenous mammalian lipids with antidiabetic and anti-inflammatory effects. We previously identified 16 different FaHFa families, such as branched palmitic acid esters of hydroxy stearic acids (paHsas); each family consists of multiple isomers in which the branched ester is at different positions (e.g., 5-and 9-paHsa). We anticipate increased need for paHsa measurements as markers of metabolic and inflammatory health. In this protocol, we provide a detailed description of the extraction of FaHFas from human or mouse tissues, their enrichment by solid-phase extraction and subsequent analysis by lc-Ms. For a sample size of 6-12, the time frame is 2-3 d.
IntroDuctIon
Type 2 diabetes mellitus (T2D) is a metabolic syndrome that affects more than 300 million people worldwide [1] [2] [3] . Metabolic changes associated with insulin resistance and T2D are complex, and they involve interactions among many major branches of cellular metabolism 4, 5 . GLUT4 is the major insulin-sensitive glucose transporter, and it is expressed at highest levels in skeletal muscle, heart and adipocytes. GLUT4 mediates glucose uptake into tissues in response to a rise in circulating insulin levels after food ingestion 6, 7 . In humans with obesity, impaired glucose tolerance or T2D, GLUT4 expression is lower in adipocytes but not in skeletal muscle 8, 9 . We generated mice with adiposespecific GLUT4 overexpression (AG4OX) to determine the impact of alterations in adipocyte GLUT4 expression on systemic insulin sensitivity. AG4OX mice display enhanced glucose tolerance in spite of obesity 7 . In these mice, expression of the glucoseregulated transcription factor, carbohydrate-responsive elementbinding protein (ChREBP), is induced in adipose tissue and drives de novo lipogenesis, which has a major role in the enhanced glucose tolerance in these mice 7, 8, 10 .
By using LC-MS, we performed a comprehensive, unbiased comparison of lipid profiles from wild-type (WT) and AG4OX mice to determine the mechanisms by which GLUT4 upregulation affects lipid metabolism and how this promotes insulin sensitivity. Untargeted global lipidomics on WT and AG4OX adipose tissue led to the identification of a novel lipid class that is markedly upregulated in AG4OX adipose depots relative to those from WT mice 6 . By using a combination of tandem MS and chemical synthesis, the structure of these lipids was determined to be branched fatty acid esters of hydroxy fatty acids, which we refer to as FAHFAs 6 .
We also showed that FAHFAs have beneficial biologic effects including enhancing glucose tolerance, promoting secretion of glucagon-like peptide-1 and insulin, augmenting insulinstimulated glucose transport and reducing proinflammatory responses 6 . By using targeted lipidomics, we identified different FAHFA family members on the basis of the structural variations of the component fatty acid and hydroxy fatty acid; the esterification of hydroxy stearic acid with palmitic acid, for example, yields the PAHSA family of FAHFAs (Fig. 1a) . Furthermore, for each FAHFA family, we identified multiple isomers that differ at the position of the ester group. The esterification of 5-hydroxy stearic acid and 9-hydroxy stearic acid with palmitic acid forms 5-PAHSA and 9-PAHSA, respectively (Fig. 1a) 6 . Owing to identical chemical formulae for 5-and 9-PAHSAs, accurate quantification of different PAHSA isomers from sera and tissues by LC-MS requires substantial optimization. We anticipate high interest in PAHSA quantification, because these are novel endogenous lipids with roles in a number of important physiological processes. This protocol describes the key steps for accurate and quantitative measurement of PAHSAs in sera and tissues.
Background
Metabolomics is a group of techniques that enable quantification of small-molecule metabolites and comparison of metabolic profiles across different biological samples 11 . The two most commonly used detection methods in modern metabolomics are NMR and MS 11 . NMR has been used in the analysis of a wide range of sample types including biofluids, tissues, plants and natural products 12 . Although the advantages of NMR are its ability to monitor different spin-1/2 nuclei, detailed structural elucidation and nondestructive data acquisition, the increased sensitivity associated with MS has resulted in wider metabolome coverage 11 . Recent advancements in the sensitivity and resolution of mass analyzers such as time-of-flight, ion trap, Fourier transform and triple quadrupole systems have enabled both discovery of novel metabolites and pathways via untargeted metabolite profiling 6, 13 , and targeted, accurate metabolite quantification via multiple reaction monitoring (MRM) 14, 15 .
In MS, samples can be introduced either directly into the detector or chromatographically resolved before MS 11 . The direct infusion method (also termed shotgun metabolomics) is highly amendable to high-throughput applications 16 . Shotgun metabolomics performed on human plasma led to the detection of important metabolite classes such as amino acids, sugars, sphingolipids and triglycerides (TGs) 17 . Although it is more time-consuming than the shotgun approach, coupling of LC, gas chromatography (GC) or capillary electrophoresis to MS allows separation and quantification of structurally similar metabolites that would not be resolved by direct infusion, and it improves detection of low-abundance metabolites that could otherwise be obscured due to signal suppression 18 . GC-MS has been used in the measurement of a diverse range of molecules including amino acids, fatty acids, sugars, sugar alcohols and amines, although only volatile compounds are directly detectable and nonvolatile species require derivatization 19, 20 . By altering the column matrix and/or mobile phase, LC-MS could be tailored to analysis of metabolites with a wide range of physical properties 11 . Hydrophilic interaction chromatography-MS has been used to effectively resolve water-soluble components of central carbon, amino acid and nucleotide metabolism 14 , whereas reversed-phase chromatography is commonly used in the analysis of lipids 13, [21] [22] [23] [24] . Given the comprehensiveness and high sensitivity of targeted MRMbased LC-MS lipidomics, we have selected this technique for the detection and quantification of PAHSAs.
Experimental design
Optimization for PAHSA measurement is divided into two sections, as follows: (i) optimization of PAHSA extraction from sera and tissues (general lipid extraction, SPE for PAHSA enrichment and sample type-dependent preparations) and (ii) optimization of PAHSA LC-MS settings (optimization of chromatography, optimization of MS detection and LC-MS sample setup). These steps are addressed in detail in subsequent sections. We also present guidelines on identification of contaminant peaks and background subtraction.
Optimization of PAHSA extraction from sera and tissues General lipid extraction. Extraction solvents determine the type of metabolites entering the analysis sample and require careful consideration. A widely used protocol for extraction of common lipid classes (e.g., fatty acids, phospholipids, sphingolipids, acylglycerols, cholesterol and cholesterol esters) is the Bligh-Dyer method, which relies on a 1:1:2 mixture of aqueous buffer:methanol: chloroform 25 . We applied the Bligh-Dyer method with slight modifications for the extraction of lipids from mouse sera and tissues, using citric acid buffer (100 mM sodium citrate tribasic dihydrate and 1 M sodium chloride, pH 3.6) as the aqueous phase; the increased salt content of this buffer enhances separation between organic and aqueous phases, whereas the reduced pH allows protonation of acidic lipids, facilitating their movement into the organic phase. We have successfully applied this method to lipid isolation for comparative lipidomics in several biological settings 21, 26, 27 .
When we used this method to extract lipids from 130 mg of WT mouse perigonadal white adipose tissue (PG WAT) as a preliminary test, we were able to detect 13/12-(note: 13-and 12-PAHSA cannot be separated by our gradient and the combined LC-MS peak is referred to as 13/12-PAHSA.), 11, 10-and 9-PAHSAs by LC-MS, but the ion counts were low for all species (Supplementary Fig. 1 ). This was due to high concentrations of neutral lipids, such as TGs, in WAT 28 . TGs are present as oils at room temperature (21-22 °C), and they make up a large proportion of the volume of the reconstituted sample. Their high concentration limits the amount of sample that can be injected while increasing ion suppression. TGs have poor solubility in water or methanol, which restricted the carrier solvent to chloroform and prevented injection of large sample volumes because chloroform has unfavorable effects on the chromatographic separation on C18 stationary phase (see 'Optimization of chromatography' below). To address this problem, we chose to fractionate the lipid extract before LC-MS to enrich the PAHSAs.
Solid-phase extraction (SPE) for PAHSA enrichment. SPE is a widely used technique that separates analytes in solution on the basis of their interactions with a solid support 29 . In the context of metabolomics, SPE enables enrichment of specific metabolite pools while removing other metabolites and contaminants that could cause signal suppression and/or impair chromatographic resolution 30, 31 . Careful choice of solid support and elution solvent allows selective enrichment of metabolites with a wide range of structures and polarities. We developed an analytical-scale SPE protocol based on our hexane:ethyl acetate flash chromatography method used during synthesis of PAHSA standards 5, 6 . In this step, a silica extraction cartridge is used. The cartridge is first washed with hexane, neutral lipids such as TGs and cholesterol esters are removed with 95:5 hexane:ethyl acetate, and then FAHFAs are eluted with ethyl acetate and collected in 1-ml fractions (PROCEDURE Steps 6-16). Unlike samples containing TGs, the samples resulting from this procedure can be reconstituted in methanol, enabling analysis of larger sample quantities through injection of higher sample volumes for LC-MS. We tested this method on a solution of synthetic 12-, 11-, 10-, 9-, 13 C-9-, 13 C-8-, 6-, 5-and 4-PAHSA standards, and we have included details on the optimization process and results in Supplementary Note 1.
Sample type-dependent preparations. In our initial experiments, we analyzed mouse serum, subcutaneous (SQ) and PG WAT, brown adipose tissue (BAT) and liver (chromatograms are in ANTICIPATED RESULTS). In principle, any liquid or homogenizable semisolid or solid material could be used. The main points to consider are sample stability and quantity for extraction. Biological materials such as sera and tissues should be flashfrozen immediately in liquid nitrogen upon collection, and they should be stored at −80 °C. To minimize sample degradation, we recommend thawing biofluids on ice. Frozen tissue aliquots should be transferred into a precooled tissue grinder on ice and homogenized immediately in the Bligh-Dyer solvent to minimize thawing before lipid isolation. It is also important to optimize the quantities of sample and internal standard for each new sample type to ensure adequate LC-MS signal for quantification without saturating the SPE column during extraction.
Our procedure specifies the use of 13 C 16 -9-PAHSA as an internal standard for quantification (PROCEDURE Step 2). To ensure consistency in the amount of standard added to each sample, the total amount of internal standard calculated for all samples to be extracted should be dissolved in chloroform first, and the chloroform should be distributed equally among the samples. A list of serum volume, tissue weights and standard quantities is provided in Table 1 as a guide; the exact quantity of standard to be added depends on the biological sample and could vary on the basis of human subject or mouse strain, and should therefore be empirically determined by the user. Typically, ion intensity of the added standard should fall within one order of magnitude of the intensity of the corresponding endogenous lipid to ensure accurate quantification. When this is not possible, the 13 C-9-PAHSA standard should be adjusted such that its ion intensity falls in the middle of the highest and lowest PAHSA isomer intensities. Although only the 13 C-9-PAHSA internal standard was used within the scope of our current protocol, incorporation of additional 13 C-PAHSA standards to accommodate the entire range of PAHSA isomer concentrations could improve the accuracy of quantification.
To ensure efficient lipid extraction, the aqueous buffer:methanol: chloroform ratio should be maintained at 1:1:2 (vol/vol/vol) or as close to this ratio as possible; when extracting lipids from serum, the volume of the serum should be taken into account as a portion of the aqueous volume. SPE was performed for all sera and tissue lipids before LC-MS. The use of more than 150 mg of adipose tissue or 80 mg of liver is not recommended, as this could cause column overloading and carryover of neutral lipids (visible as a clear to yellow oil) into the ethyl acetate fraction during elution. Typical serum volume for extraction is 150-300 µl. A larger serum volume can be used if it is not limited by sample availability; however, care should be taken to prevent overloading of the SPE column (we have previously extracted up to 900 µl of human serum successfully).
Optimization of PAHSA LC-MS settings
Optimization of chromatography. PAHSAs were initially identified by global lipidomics of WT and AG4OX mice in negative ionization mode, using a reversed-phase water-isopropanol LC gradient and C4 or C18 columns 6, 27 . This chromatographic method is optimized for lipidomics of a wide range of lipid families, and it does not separate different PAHSA isomers. We therefore needed to develop new LC conditions for the more challenging separation of PAHSA isomers.
The conditions described in the PROCEDURE (Step 27) were optimized using a solution containing 12, 11, 10, 9, 13 C-9, 13 C-8, 6, 5 and 4-PAHSA standards on a C18 column (3 µm, 100 Å, 250 × 2.0 mm) 6 . This column is longer and the particle size is smaller than those in the columns we use for global lipidomics. The increased column length allows more time for the peaks to separate, and the smaller particle size usually results in sharper peaks. More details on the development of this LC method can be found in Supplementary Note 2.
Optimization of MS detection. The low biological abundance of PAHSAs relative to major lipid families such as fatty acids and acylglycerols presented a challenge for measurement of these lipids in sera and across multiple tissue types. To reduce the quantity of sample necessary for analysis and to improve quantification, we developed a targeted approach using a triplequadrupole mass spectrometer operated in MRM mode.
MRM has emerged as a powerful analytical technique that enables targeted, simultaneous quantification of multiple metabolites with high sensitivity 14, 15, 27, 32, 33 . By subjecting the metabolite of interest (precursor ion) to an optimized set of fragmentation conditions and monitoring a specific fragment (product ion) that consistently originates from the precursor, MRM takes advantage of the characteristic precursor-to-product ion transition specific to each metabolite, allowing unambiguous identification and detection of known metabolites with high signal-to-noise ratio (Fig. 1b) 6, 15, 32 . As most metabolites with distinct structures will generate unique transitions, it is possible for many species to be monitored at once. Given that many metabolites fragment to yield multiple product ions at consistent ratios, multiple transitions could be optimized and monitored for each metabolite to increase the confidence of identification. Tandem MS of 9-PAHSA (m/z 537) in negative ionization mode yielded three characteristic product ions at m/z 255, 281 and 299 (Fig. 1c) , corresponding to precursor-to-product ion transitions m/z 537 → 255, m/z 537 → 281 and m/z 537 → 299 (Fig. 1d) . Fragmenter voltage for the precursor ion and collision energies for all fragments were empirically optimized to maximize signalto-noise ratio for each transition.
Of the fragments observed, m/z 255 corresponds to palmitic acid, m/z 299 corresponds to hydroxystearic acid and m/z 281 corresponds to C18:1 fatty acid (Fig. 1c) 6 . 9-PAHSA consistently fragments with the relative fragment abundances m/z 255 > 281 > 299, which is reflected in the relative abundances of the corresponding precursor-to-product ion transitions (m/z 537 → 255 >; m/z 537 → 281 >; m/z 537 → 299; Fig. 1d) . The m/z 537 → 255 transition yielded the highest ion count in all PAHSA (12, 11, 10, 9, 6, 5 and 4) standards tested (Fig. 1e,f) , which is a probable consequence of stability of the palmitic (m/z 255) ion relative to the more chemically labile hydroxystearic (m/z 299) ion, which undergoes further fragmentation to yield C18:1 fatty acid (m/z 281). It is worth noting that although m/z 537 → 255 is the major transition for all PAHSA standards, relative ratios of detected transitions depend on isomer position (Fig. 1e,f) . A lower 255/281 ratio was found for 6-PAHSA relative to 9-12-PAHSAs, whereas m/z 537 → 255 was the only significantly detectable transition for 4-PAHSA (Fig. 1e,f) . The m/z 537 → 255 transition is therefore the most reliable choice for use in quantification; however, we included all three transitions in our measurements, given that the ratios among these transitions are FAHFAdependent and that they provide a simple method for excluding non-PAHSA contaminants.
LC-MS sample setup.
We recommend performing LC-MS on five biological replicates for each sample type in order to check that there is no drastic shift in the retention times of the peaks. There should be no significant carryover in a blank sample analyzed after the fifth biological sample. Recommended injection volumes and an example injection order (worklist) are detailed in PROCEDURE (Step 27). Blank samples should be run at the beginning and end of each worklist to completely remove carryover from previous and for subsequent data sets. A solution of 12, 11, 10, 9, 13 C-9, 13 C-8, 6, 5 and 4-PAHSA standards (PAHSA standard ladder (PSL)) should also be run before and after the biological samples to confirm no loss of column resolution. Assuming that you are confident that there is no significant carryover after five sample runs (~10 h), we recommend running a blank sample at the end of every five to six biological samples (rather than after each sample). The column can also be washed with isopropanol at the end of the experiment to thoroughly dissociate any remaining bound lipids before storage in solvents recommended by the manufacturer. If comparison between two groups of samples (e.g., WT versus knockout) is necessary, samples from different groups should be alternated in the worklist to minimize any time-dependent fluctuations in acquisition conditions.
Although retention time should not change drastically within each data set, we find that there is some variability in retention time across data sets that are run on separate days. This effect can be reduced by preparing separate bottles of A (100% water) and B (100% methanol) mobile phase solutions and using the LC solvent mixer to achieve the final elution percentage. It is also acceptable to prepare one bottle of 93% methanol in water; however, this could lead to more retention time drift across data sets because of measuring inaccuracies. Samples from different data sets can be aligned based on retention time of the 13 C-9-PAHSA internal standard in each sample. Given solvent evaporation over time, we recommend reconstitution of no more than two samples in chloroform and reconstitution of no more than four samples in methanol at once for LC-MS, assuming a 10-µl volume per sample; solvent addition should be staggered corresponding to the order of the worklist, and all prepared samples should be kept at 10 °C to minimize solvent evaporation.
Contaminants and background subtraction
Although MRM targets the precursor-to-product ion transition unique to each metabolite, false positives are still possible when two different metabolites share similar precursor and product ion masses, because the mass spectrometer is not set up to obtain the exact masses of the ions (in MRM). Therefore, monitoring of multiple transitions per metabolite increases the confidence of identification. For the majority of PAHSA isomers, appearances of peaks for all three transitions at identical retention times and with the major peak corresponding to m/z 537 → 255 are important criteria for the PAHSA structure assignment, and simultaneous monitoring of all three transitions enables identification of contaminant peaks. We provide an example of the identification of false positives under ANTICIPATED RESULTS, in which the sphingolipid ceramide shares all three transitions with PAHSAs but can be distinguished from the latter on the basis of differences in the ratio of the three transitions and different retention times.
In addition to non-FAHFA contamination that could be introduced during the FAHFA isolation process, it is also important to note that the use of SPE columns and aqueous buffers during the FAHFA extraction process yields some background signal in the FAHFA MRM channel. We have observed signals that correspond to ~15% of the total serum signal as background (see below). This background signal is negligible for liver and adipose tissues, which have much higher FAHFA levels (ANTICIPATED RESULTS). Consequently, for serum analysis, we recommend carrying out a blank (water instead of serum) extraction, followed by SPE and LC-MS. To ensure accurate quantification, the background signal from this blank can then be subtracted from the sample signal. We have also found that the instrument, especially the injector, needs to be rigorously cleaned or replaced to ensure that there is no residual background due to injecting large amounts of standards. The procedure provides instructions for lipid extraction, fractionation and LC-MS of 6-12 samples. Wear appropriate chemical-resistant protective equipment ! cautIon For all work involving laboratory animals, adhere to all guidelines and regulations under protocols approved by the investigator's institutional animal research review committee. All personnel working with laboratory animals should be trained in animal handling and use appropriate protective equipment.  crItIcal Use the same grade of solvent as LC mobile phase for cleaning of spatulas and glassware related to LC-MS. Avoid all detergents for cleaning, as this will cause substantial instrument contamination. It is highly recommended that weighing equipment and glassware be set aside specifically for LC-MS use. Use glassware instead of plasticware whenever possible. Transfer solvents using either Pasteur pipettes or glass serological pipettes. Human serum ! cautIon Adhere to all guidelines and regulations associated with collection and use of human serum. All personnel working with human serum samples should be informed of risks associated with potential blood-borne pathogens and be trained in correct sample handling techniques. Use appropriate personal protective equipment. WT and AG4OX mice ! cautIon Adhere to all guidelines and regulations under protocols approved by the investigator's institutional animal research review committee; all personnel working with laboratory animals should be trained in animal handling and use appropriate protective equipment (i.e., gloves, face mask and protective clothing) as set by the institution's animal facility. Water for citric acid buffer (molecular biology grade; Fisher Scientific, cat. no. MT-46-000-CM) Water for LC-MS (B&J Brand Multipurpose ACS, HPLC; VWR, cat. no. BJ365) Methanol (B&J Brand Multipurpose ACS, HPLC; VWR, cat. no. BJ230) ! cautIon Methanol is toxic and highly flammable, and it should be handled in the fume hood. Isopropanol (B&J Brand Multipurpose ACS, HPLC; VWR, cat. no. BJ323) ! cautIon Isopropanol is flammable and should be handled in the fume hood. Hexane (B&J Brand Multipurpose; VWR, cat. no. BJ212) ! cautIon Hexane is harmful, dangerous for the environment and highly flammable, and it should be handled in the fume hood. Ethyl acetate (B&J Brand Multipurpose ACS, HPLC; VWR, cat. no. BJ100) ! cautIon Ethyl acetate is highly flammable and an irritant, and it should be handled in the fume hood. Chloroform (contains amylene preservative; VWR, cat. no. BJ049) ! cautIon Chloroform is harmful and should be handled in the fume hood. DMSO (B&J Brand Multipurpose ACS, HPLC; VWR, cat. no. BJ081) ! cautIon DMSO can permeabilize skin to additional chemicals; wear DMSO-resistant protective equipment when you are handling it. Diethyl ether anhydrous (ACS reagent, ≥99.0%, contains butylated hydroxytoluene (BHT) as inhibitor; Sigma-Aldrich, cat. no. 673811) ! cautIon Diethyl ether is harmful and extremely flammable, and it should be handled in the fume hood. Ammonium hydroxide (28% ammonia in water, ≥99.99% trace metals basis; Sigma-Aldrich, cat. no. 338818) ! cautIon Ammonium hydroxide is corrosive and dangerous for the environment, and it should be handled in the fume hood  crItIcal Ammonia solution is volatile and should be stored tightly capped at 4 °C; when stored at this temperature, no change in data quality was observed for at least 6 months. Ammonium acetate (99.999% trace metals basis; Sigma-Aldrich, cat. no. 372331)  crItIcal Ammonium acetate is hygroscopic, and should be stored in a drybox (see 'Dry-Keeper desiccator cabinet' in the Equipment section) with desiccant (see 'DRIERITE' in the Reagents section); water absorption will occur over time and the bottle should be replaced when significant stickiness and clumping are observed. Sodium citrate tribasic dihydrate (for molecular biology, ≥99.0%; Sigma-Aldrich, cat. no. C8532) Sodium chloride (Fisher BioReagents, ≥99.5%; Fisher Scientific, cat. no. BP358-212) Hydrochloric acid (ACS grade, 36.5-38.0%; EMD Millipore, cat. no. HX0603) ! cautIon Hydrochloric acid is corrosive and should be handled in the fume hood. ) ; VWR, cat. no. JTL058) ! cautIon Indicating DRIERITE is toxic and dangerous for the environment, and it should be handled in the fume hood. Sodium sulfate, ACS reagent, ≥99.0%, anhydrous, granular (Sigma-Aldrich, cat. no. 239313) ESI-L low-concentration tuning mix (Agilent Technologies, cat. no. G1969-85000) ! cautIon Tuning mix contains mass standards in 95:5 acetonitrile:water; acetonitrile is harmful and highly flammable, and it should be handled in the fume hood  crItIcal Tuning mix should be stored at 4 °C, and small portions of the tuning mix should be removed as needed for MS calibration. 13 C 16 -5-PAHSA, 13 C 16 -9-PAHSA (Fig. 2) and nonlabeled 12-through 4-PAHSA standards were chemically synthesized according to standard synthetic techniques. 1 13 C 4 -9-PAHSA standard is commercially available (Cayman Chemical, cat. no. 17725)  crItIcal heavily deuterated PAHSA standards show a substantial forward retention time shift relative to endogenous lipids when analyzed using our LC method (Fig. 2) ; consequently, we strongly recommend the use of 13 (Fig. 3a) (Fig. 3a) , transfer again into second glass vial to further remove aqueous contaminants Dry under N 2 , store at -80 °C Centrifuge at 2,200g, 6 min, 4 °C Add chloroform (Table 1) Add methanol (Table 1) Add citric acid buffer (Table 1) Up to 6 months before experiment Mobile phase A Carefully weigh 192.7 ± 0.5 mg of ammonium acetate into a clean, dry 1-liter glass bottle. Filter 500 ml of water through a solvent filtration unit with a 0.2-µm nylon membrane, and then transfer the water into a glass bottle containing ammonium acetate; sonicate for 20 min in a room-temperature water bath to further degas and to ensure complete solvation of ammonium acetate. By using the syringe-Pasteur pipette setup in Figure 3a , add to the resulting solution 0.5 ml of 10% (vol/vol) ammonia hydroxide solution to achieve a final ammonium hydroxide concentration of 0.01% (vol/vol). Mix thoroughly by gently swirling the bottle without allowing any solvent to reach the bottle cap. Use immediately.  crItIcal 1.7 ml of mobile phase A and 22.3 ml of mobile phase B are required per sample for the Luna column separation. The total volume of mobile phases should be calculated on the basis of the number of samples and the amount of additional solvent (100-200 ml) necessary for blanks and purging LC lines. A sample worklist is provided under PROCEDURE (Step 27). All solutions should be freshly prepared. Fresh solutions can be used for up to 48 h with no change in data quality. Mobile phase B Carefully weigh 385.4 ± 0.5 mg of ammonium acetate into a clean, dry 1-liter glass bottle. Filter 1 liter of methanol through a solvent filtration unit with a 0.2-µm nylon membrane, and transfer methanol into the glass bottle containing ammonium acetate; sonicate for 20 min in a room-temperature water bath to further degas and to ensure complete solvation of ammonium acetate. By using the syringePasteur pipette setup in Figure 3a , add to resulting solution 1 ml of 10% (vol/vol) ammonia hydroxide solution to achieve a final ammonium hydroxide concentration of 0.01% (vol/vol). Mix thoroughly by gently swirling the bottle while not allowing any solvent to reach the bottle cap. Use immediately.  crItIcal Solubility of ammonium acetate is higher in water than in methanol; examine mobile phase B to confirm complete solvation of ammonium acetate before use. 
Column wash buffer

1|
Remove the glass vial containing 10 mM or 100 µM 13 C 16 -9-PAHSA solution from −80 °C storage, and then equilibrate it to room temperature for 20 min.
2|
Prepare a working solution of 13 C 16 -9-PAHSA (0.5-5 pmol per sample) in chloroform (2-3 ml per sample) and store it at 4 °C before extraction.  crItIcal step Calculate the total chloroform volume for the number of samples plus one, using 2-3 ml of chloroform per sample. The amount of 13 C 16 -9-PAHSA needed is sample-dependent, and it should be determined empirically by the user; recommended values for selected WT mouse tissues and human or WT mouse serum are provided in table 1.
3|
Cool the sample vials and tissue grinders on ice for at least 5 min before performing the extraction.  crItIcal step Cooling glassware for too long could lead to water condensation inside tissue grinders. lipid extraction 5| Follow either option A or option B for lipid extraction from tissues or sera, respectively. Figure 3 contains an image of the required glassware and summaries of the workflows. ! cautIon To minimize risk of injury by broken glass when using the syringe-Pasteur pipette setup in Figure 3a , take caution when connecting or removing the pipette to and from the Teflon tubing connected to the syringe.  crItIcal step The inclusion of a solvent-only negative control from this step onward is strongly recommended, as this enables background subtraction and more accurate quantification if any background signal is present. (Fig. 3b) .
(ii) Using the syringe-Pasteur pipette setup in Figure 3a or glass serological pipette, immediately add 1.5 ml of citric acid buffer, followed by 1.5 ml of methanol and 3.0 ml of chloroform containing 13 C 16 -9-PAHSA standard (see Step 2  and table 1 for preparation of standards in chloroform).  crItIcal step Tissue samples should be extracted immediately without thawing. Prolonged keeping of samples in aqueous buffer could lead to potential additional FAHFA metabolism. Given rapid extraction of lipids upon solvent addition, buffer and solvents can be used at room temperature; however, the chloroform-containing standard should be kept at 4 °C before extraction to minimize changes in standard concentration owing to evaporation. (iii) Homogenize by performing 40 strokes on ice using pestle A.
! cautIon Splashing may occur, and some initial resistance may be felt especially in the case of liver; homogenize slowly and wear appropriate personal protective equipment. ! cautIon Glass vials will tolerate this spinning speed without shattering. In the rare event of a vial breaking, dispose of it appropriately while wearing personal protective equipment. Recover the sample only if it does not present a risk to the user to do so. (ix) Place the centrifuge tubes containing vials back on ice. One sample at a time, gently remove the chloroform (bottom) layer using the syringe-Pasteur pipette setup in Figure 3a , and transfer chloroform into a clean 4-ml sample vial at room temperature. ? trouBlesHootInG (x) Transfer chloroform-containing lipids ( Step 5A(ix)) again into a second 4-ml sample vial at room temperature. Residual water will stick to the sides of the first glass vial during transfer, thus allowing further removal of aqueous contaminants.  crItIcal step The second transfer can be performed with a Pasteur pipette attached to a bulb to enhance transfer speed and to minimize solvent evaporation. (xi) Dry the samples for 30-45 min at room temperature under a gentle stream of nitrogen, proceed directly to fractionation (Step 6) or briefly flush each sample with nitrogen and store the samples tightly capped at −80 °C. ? trouBlesHootInG  pause poInt Dried lipids are stable at −80 °C for at least 6 months. (B) extract lipids from human or mouse sera • tIMInG 1.5 h (i) Transfer thawed sera (typical volume for extraction is 150-300 µl) to an 8-ml sample vial on ice, and then add citric acid buffer to a final volume of 1 ml (Fig. 3c) .  crItIcal step Extraction solvent volume should be increased if you are using higher sera volumes (i.e., 1.5-2.0 ml aqueous:1.5-2.0 ml methanol:3.0-4.0 ml chloroform for 300-900 µl sera); maintain the aqueous fraction:methanol: chloroform ratio at 1:1:2 (vol/vol/vol). (ii) By using the syringe-Pasteur pipette setup in Figure 3a or glass serological pipette, immediately add 1 ml of methanol followed by 2 ml of chloroform containing 13 C 16 -9-PAHSA standard (see Step 2 and table 1 for preparation of standards in chloroform).  crItIcal step Solvents should be added quickly. Keeping samples for too long in aqueous buffer could lead to potential additional FAHFA metabolism. (iii) Shake each vial vigorously for 30 s by hand at room temperature.
! cautIon Cap the vials tightly to prevent spillage. (iv) Vortex each vial for 15 s at room temperature.
! cautIon Cap the vials tightly to prevent spillage. (v) Transfer the sample vials into clean 50-ml centrifuges, and centrifuge them at 2,200g for 6 min at 4 °C.
! cautIon Glass vials will tolerate this spinning speed without shattering. In the rare event of a vial breaking, dispose of appropriately while wearing personal protective equipment. Recover the sample only if this does not present a risk to the user. (vi) Replace the samples back on ice, one sample at a time, gently remove the chloroform (bottom) layer using the syringePasteur pipette setup in Figure 3a , and then transfer the chloroform into a clean 4-ml sample vial at room temperature. (vii) Transfer the chloroform-containing lipids again into a second 4-ml sample vial at room temperature to remove residual aqueous contaminants.  crItIcal step The second transfer can be performed with a Pasteur pipette attached to a bulb to enhance transfer speed and to minimize solvent evaporation. (viii) Dry the samples for 30-45 min at room temperature under a gentle stream of nitrogen, and proceed directly to fractionation (Step 6) or briefly flush each sample with nitrogen and store the samples tightly capped at −80 °C. ? trouBlesHootInG  pause poInt Dried lipids are stable at −80 °C for at least 6 months.
FaHFa enrichment via fractionation
• tIMInG 4 h 6| Remove tissue or serum lipids (see Step 5A or 5B for lipid extraction from tissue or serum, respectively) from −80 °C storage and equilibrate them to room temperature for 20 min (Fig. 4) .  crItIcal step All steps are performed at room temperature. An image of the required glassware and a summary of workflow are given in Figure 4 .
7| While equilibrating samples, connect SPE columns to extraction manifold (Fig. 4a) .
8|
Condition the SPE column with 15 ml of hexane, allow the solvent to flow through the column by gravity, and then collect the flow-through in 20-ml glass vials.  crItIcal step Do not disturb the column bed with the pipette. Gently pipette toward the column wall, and allow the solvent to flow onto the column bed for all steps.
? trouBlesHootInG 9| While conditioning the column, reconstitute each lipid sample in 200 µl of chloroform and vortex the samples for 20 s at room temperature.
10| Check that hexane from
Step 9 has completely flown through the column before loading the sample. Load the sample onto the column, allow the solvent to flow through the column by gravity and collect the flow-through in 20-ml glass vials; vials from Step 9 can be kept in place and reused for this step. ? trouBlesHootInG 11| Wash each sample vial with 100 µl of chloroform, vortex for 10 s, load the wash onto the column, allow the solvent to flow through the column by gravity and collect the flow-through in 20-ml glass vials; vials from Step 10 can be kept in place and reused for this step. Discard 20-ml vials containing hexane and chloroform, and replace them with new 20-ml vials for Step 12. 
Ms parameters
Instrument
Agilent 6410 triple-quadrupole mass spectrometer 25| Set the flow rate to 0 ml/min and connect the column with an attached in-line filter to LC.  crItIcal step Before connecting the column, confirm that all incompatible solvents from previous sample runs have been fully displaced.
26| Set the solvent to 7% A, 93% B, start the flow rate at 0.1-0.15 ml/min and gradually increase it to 0.2 ml/min. Equilibrate the column at 0.2 ml/min for at least 30 min, and confirm that pressure has stabilized before the sample run. Depending on the LC setup, the pressure should stabilize between 210 and 240 bars. Centrifuge the samples at 2,000-2,500g for 6-10 min at 4 °C to improve phase separation; in a few instances, thick precipitates and a lack of phase separation have been observed for human serum samples; vortex these samples thoroughly and re-spin them for a clear organic phase Aqueous contamination Small quantity of aqueous carryover can be dried using nitrogen with increased drying time and gas pressure; drying of aqueous carryover typically leaves behind white solids (salts from citric acid buffer) that will have low solubility in chloroform or 9:1 heptane:isopropanol and therefore only minimally enter the SPE or HPLC column; trace amounts of salts that do enter the columns will be separated from the FAHFA fraction and typically have little effect on FAHFA enrichment In the case of significant aqueous carryover, it is advisable that the extraction be repeated with the new sample. Take care when isolating the chloroform layer from the extraction mixture, and use the syringe-Pasteur pipette setup in Figure 3a for improved control Dried lipids appear pink to dark red in color
Blood pigments The relatively low pH of citric acid buffer will lead to extraction of blood pigments from tissues; consequently, lipids from highly vascularized tissues and sera containing residual red blood cells will appear pink to dark red upon drying. This can be minimized by quickly washing freshly excised tissues with PBS before freezing; blood pigments will also be removed during SPE • tIMInG Steps 1-3, prepare reagents and glassware for extraction: 30 min
Step 4, prepare sera and tissue samples: 30 min
Step 5A, extract lipids from mouse tissues: 2 h
Step 5B, extract lipids from human or mouse sera: Figure 5 . Individual data sets are aligned on the basis of the retention time of the 13 C 16 -9-PAHSA internal standard. Endogenous 13-, 12-, 11-, 10-, 9-, 8-, 7-and 5-PAHSAs were observable via our method, with 9-PAHSA being the major isomer in a majority of samples (Fig. 5a,b) . Highest total PAHSA level is found in BAT, with adipose tissues displaying widest isomeric range; 13/12-, 9-and 8-PAHSAs were the only detectable isomers in liver (Fig. 5b) . PAHSA isomeric distribution is tissuedependent, and it could be affected by additional factors such as animal strain and metabolic state. Details on the As was previously mentioned ('Contaminants and background subtraction' section in the INTRODUCTION), we have detected a small amount of background signal as a result of the FAHFA extraction process, which occupies ~15% of the serum signal (Fig. 6) , but it is negligible in the case of liver and adipose tissues given the high PAHSA signals in those tissues (Fig. 5b) . Consequently, the inclusion of a solvent-only negative control, especially for sera, will allow background subtraction and improve the accuracy of PAHSA quantification.
Although MRM enables the detection of specific metabolites based on their unique MS/MS fragmentations, it is important to note that false positives are still possible because of the lack of exact mass. We have found during our analysis that the sphingolipid ceramide can be detected with PAHSA transitions. As Figure 7a illustrates, LC-MS of mouse serum and tissues revealed a highly abundant peak at ~95 min with higher m/z 537 → 281 ion count than m/z 537 → 255. Tandem MS of the 95-min peak yielded fragments closely matching those from d18:1/16:0 ceramide (Fig. 7b) . Given that the loss-of-proton precursor ion for d18:1/16:0 ceramide is m/z 536, the 95-min peak (detected under PAHSA MRM parameters with m/z 537 as precursor) represents naturally occurring isotopes of C16 ceramide (i.e., 13 C-d18:1/16:0 ceramide; Fig. 7b ). Co-injection with a d18:1/16:0 ceramide standard and WT mouse gastrocnemius muscle (GNM) validated this ion as a d18:1/16:0 ceramide (Fig. 7c) . The presence of ceramide in fractionated mouse lipids was not surprising, given that ethyl acetate elution during SPE was not FAHFA specific and could lead to co-elution of additional lipids with similar lipid-matrix interactions. A more thorough survey of fractionation conditions could improve the specificity of FAHFA isolation and minimize co-elution of additional lipids. 
